WearOptimo’s life-saving Microwearable sensor technology heads into production, with $30 million deal. A revolutionary healthcare technology with potential to save millions of lives globally is poised to enter mass-production following the announcement of a $30 million deal in Australia. The project will fund an advanced technology facility in Brisbane, Australia – a critical step to WearOptimo making and distributing its Microwearable TM sensor health technology worldwide. WearOptimo’s inexpensive, pain-free wearable devices can give patients and their doctors early warning of life-threatening events such as heart attacks, heat stroke and other conditions. They represent a breakthrough in personalised medicine. A partnership between the Queensland Government, The Australian National University (ANU), WearOptimo, and the Australian National Fabrication Facility (ANFF) will invest $30 million in a globally-competitive, high-tech manufacturing facility – based in Australia – for production of Microwearable sensors to reach into key healthcare markets.